Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Thousands of Ebola survivors face severe pain, possible blindness

Thousands of West Africans who were infected with the Ebola virus but survived it are suffering chronic conditions such as serious joint pain and eye inflammation that can lead to blindness, global health experts said on Friday. Ebola survivors who fought off the most severe bouts of infection are the most likely to suffer ongoing […]

Read More »

Eating oily fish may help kids avoid nasal allergies

Children who eat certain types of fish may be less likely to develop nasal allergies, according to a study from Sweden. Researchers studied what children ate at age eight and then monitored whether they developed nasal inflammation due to allergies or colds by age 16. Regular consumption of oily fish like salmon was linked a […]

Read More »

Pfizer, Bristol revive cancer drugs that rev up immune system

Some of the most heralded new cancer drugs fight the disease by removing brakes on the immune system. Now a few leading drugmakers are paying attention to a second, opposing force: medicines that accelerate the immune system’s attack. Pfizer Inc, which is lagging rivals in the lucrative field of cancer immunotherapies, has been the first […]

Read More »

Sanofi links with Evotec to tap stem cells for diabetes care

French drugmaker Sanofi is linking with Evotec to develop stem cell-based treatments for diabetes, under a deal that could earn the German biotech firm more than 300 million euros ($327 million). Sanofi, a leading supplier of diabetes care, said on Friday the aim was develop beta cell-modulating diabetes therapies that could reduce or eliminate the […]

Read More »

Biogen Sinks Some More After Doctors Fear More Brain Infections Will Occur in Patients Taking Drugs Like Tecfidera

Biogen Inc. shares sank after doctors in a top medical journal said more instances of brain infections may occur in people taking a type of medication that includes the drugmaker’s top-selling multiple sclerosis treatment. The shares fell 5.6 percent to $316.60 at the close in New York following the publication of the letter in the […]

Read More »

Allergan gets DoJ subpoena over generic drug pricing

Allergan Plc said on Thursday it received a subpoena from the U.S. Department of Justice seeking information on marketing and pricing of its generic drugs. The department has previously issued subpoenas to generic drugmakers, including Impax Laboratories Inc and Lannett Co Inc, as part of investigations into rising prices for generic drugs. ( ( The […]

Read More »

GSK Receives Approval for BREO ELLIPTA for the Treatment of Adults With Asthma

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA–(Marketwired – Aug 6, 2015) – GSK (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) announce the approval in Canada of BREO® ELLIPTA® (fluticasone furoate/vilanterol dry powder for oral inhalation) for the once-daily maintenance treatment of asthma in patients aged 18 years and older with reversible obstructive airways disease. BREO® […]

Read More »

Urban ERs See High Rates of Hepatitis C Infection

WASHINGTON, Aug. 6, 2015 /PRNewswire-USNewswire/ — An urban emergency department that set up a hepatitis C testing protocol saw high rates of infection among intravenous drug users and Baby Boomers, with three-quarters of those testing positive unaware they were infected.  The results of a screening and diagnostic testing program for hepatitis C were reported online Tuesday […]

Read More »

Medtronic to recall loading system for heart device: FDA

Medtronic Plc will recall 6,912 units of the loading system of a recently approved heart device after reports of the presence of particulates, the U.S. Food and Drug Administration said. The FDA has classified the recall as “Class 1”, implying there is a reasonable probability that the use of or exposure to the product could […]

Read More »

Why This Is The Hardest Of Times To Be A Physician In America

Last week, Dr. Pearl kicked off a three-part series on the physician experience. His first installment revealed Why This Is The Best Of Times To Be A Physician In America. With apologies to Charles Dickens, just as now is the best of times to practice medicine, it is also the worst of times to do […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom